By DONALD G. McNEIL Jr.
Glaxo and Johnson & Johnson top a new measure of how drugmakers do against antibiotic-resistant bacteria, which are becoming a global emergency.
Published: January 22, 2018 at 07:00PM
from NYT Health http://ift.tt/2Dxuy4Y
via IFTTT
from WordPress http://ift.tt/2rzar4D
via IFTTT
No comments:
Post a Comment